BuybackMay 12, 2026, 06:32 AM
Zimmer Biomet Increases Share Buyback Expectation to $1B
AI Summary
Zimmer Biomet Holdings, Inc. announced its intent to repurchase up to $1.0 billion of its common stock during fiscal year 2026. This amount is a $250 million increase from the company's previously disclosed capital allocation assumptions for the year. The repurchases will be made under the company's existing $1.5 billion share repurchase authorization, which was approved by the Board of Directors in February 2026.
Key Highlights
- Zimmer Biomet plans to repurchase up to $1.0 billion of its common stock in fiscal year 2026.
- This represents a $250 million increase from the company's previous capital allocation assumptions.
- The repurchases will be conducted under the existing $1.5 billion share repurchase authorization.
- The $1.5 billion authorization was approved by the Board of Directors in February 2026.